HealthEquity, Inc. (NASDAQ:HQY) Receives Average Rating of “Moderate Buy” from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned an average rating of “Moderate Buy” from the fourteen analysts that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $110.5714.

A number of research analysts have weighed in on HQY shares. Jefferies Financial Group set a $108.00 price target on shares of HealthEquity in a research note on Thursday, February 19th. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research note on Monday, June 1st. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Raymond James Financial set a $100.00 price objective on shares of HealthEquity in a report on Tuesday, February 17th. Finally, Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st.

Insider Activity

In other news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,081 shares of company stock worth $1,193,000 over the last ninety days. Insiders own 1.60% of the company’s stock.

Institutional Trading of HealthEquity

Hedge funds and other institutional investors have recently made changes to their positions in the business. Capricorn Fund Managers Ltd acquired a new stake in shares of HealthEquity in the fourth quarter valued at approximately $6,926,000. King Luther Capital Management Corp raised its holdings in shares of HealthEquity by 60.6% in the third quarter. King Luther Capital Management Corp now owns 80,584 shares of the company’s stock valued at $7,637,000 after purchasing an additional 30,394 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of HealthEquity by 11.5% in the third quarter. JPMorgan Chase & Co. now owns 1,205,077 shares of the company’s stock valued at $114,205,000 after purchasing an additional 124,283 shares during the last quarter. Vanguard Group Inc. increased its holdings in HealthEquity by 2.9% during the third quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock worth $828,883,000 after buying an additional 243,549 shares during the last quarter. Finally, Congress Asset Management Co. increased its holdings in HealthEquity by 36.3% during the fourth quarter. Congress Asset Management Co. now owns 101,816 shares of the company’s stock worth $9,327,000 after buying an additional 27,102 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Stock Performance

Shares of HQY opened at $88.34 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. HealthEquity has a twelve month low of $72.76 and a twelve month high of $106.60. The firm’s 50 day moving average price is $84.64 and its two-hundred day moving average price is $85.87. The firm has a market cap of $7.39 billion, a P/E ratio of 33.09, a PEG ratio of 1.49 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts forecast that HealthEquity will post 3.92 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.